Bismuth subsalicylate Completed Phase 2 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002682Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach